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Abstract 
 
Drug abuse influences the pathological of oral diseases. There are scarce evidence-based data on the oral 
manifestations related to drug abuse. This systematic review aim to assess the oral manifestations related to drug 
abuse. Electronic databases were searched using keywords include oral manifestations, drug abuse and systematic 
review. Observational studies published until September 2018 with the outcome of oral manifestations related to 
drug abuse were included. Data were extracted as percentage included drug type, route of administration, and oral 
manifestations. Study quality was assessed using the quartile score of Scopus index. The systematic review of 17 
studies revealed that methamphetamine (53%), heroin (41%), cannabis (35%), and cocaine (35%) were the most 
frequent abused drugs from 10139 samples. The routes of administration include smoking (58%), inhalation 
(35%), injection (35%), and oral route (17%), with duration of use ranged from one year to forty years. The most 
significant of oral manifestations reported were periodontal diseases (76%), dental caries (76%), and xerostomia 
(41%). Adverse drug reaction in oral cavity may cause, directly or indirectly, immune suppression, susceptibility 
to infections, and oral pathologies due to chemical composition and mechanism of action specifically to drug type 
related with duration of use and route of administration. 
 
Keywords: Drug abuse, oral manifestations, systematic review 
 
Abstrak 
 
Penyalahgunaan narkoba mempengaruhi patologis penyakit mulut. Data tentang manifestasi oral yang terkait 
dengan penyalahgunaan narkoba berdasarkan bukti masih jarang. Tinjauan sistematis ini bertujuan untuk menilai 
manifestasi oral yang terkait dengan penyalahgunaan narkoba. Pencarian pada database elektronik menggunakan 
kata kunci yaitu manifestasi oral, penyalahgunaan narkoba dan tinjauan sistematis. Studi observasional yang 
diterbitkan hingga September 2018 dengan hasil manifestasi oral yang terkait dengan penyalahgunaan narkoba 
dimasukkan. Data diekstraksi sebagai persentase termasuk jenis obat, rute pemberian, dan manifestasi oral. 
Kualitas studi dinilai menggunakan skor kuartil dari indeks Scopus. Tinjauan sistematis dari 17 studi 
mengungkapkan bahwa metamfetamin (53%), heroin (41%), ganja (35%), dan kokain (35%) adalah obat yang 
paling sering disalahgunakan dari 1.0139 sampel. Cara penggunaan meliputi merokok (58%), inhalasi (35%), 
injeksi (35%), dan rute oral (17%), dengan durasi penggunaan berkisar dari satu tahun hingga empat puluh tahun. 
Manifestasi oral yang paling signifikan yang dilaporkan adalah penyakit periodontal (76%), karies gigi (76%), 
dan xerostomia (41%). Reaksi obat yang merugikan dalam rongga mulut dapat secara langsung maupun tidak 
langsung menyebabkan, imunosupresi, kerentanan terhadap infeksi, dan patologi oral dikarenakan komposisi 
kimia dan mekanisme kerja khusus untuk setiap jenis obat dan yang terkait dengan durasi penggunaan dan rute 
penggunaan. 
 
Kata kunci: Penyalahgunaan narkoba, manifestasi oral, tinjauan sistematis 
 
 
INTRODUCTION 
 
Drug abuse or drug use disorder is the use of a 
substance for a purpose not consistent with legal 
or medical guidelines, as in the non-medical use 
of prescription medications.
1
 The World Drug Re-
port 2018 by the UN Office on Drugs and Crime 
(UNODC) estimated that 5,6% people aged 15-64 
years had used an illicit drug at least once in 
2016.
2
 The type and frequency of drugs used 
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worldwide varied substantially across region in-
cluding cannabis (182 million), opioids (34 mil-
lion), methamphetamine (34 million), ecstasy (21 
million) and cocaine (19 million).
2 
In Indonesia, 
based on the 2017 national survey on substance 
abuse by the Badan Narkotika Nasional (BNN) 
reported that 3.3 million people aged 10-59 years 
(1.77%) had used illicit drugs. However, the pre-
valence showed that there was significant decree-
sed from 2014 (2.18%).
3
  
Drug abuse contribute to the global burden of 
disease through the adverse effects of its use in-
cluding the acute toxic effects, the acute effects of 
intoxication, development of dependence, and 
risk factors for chronic disease due to repeated ex-
posure. Strong evidence supports that drug-indu-
ced psychotic and drug dependence are the acute 
and chronic consequences of substance abuse.
4
 
Drug abuse is chemical substances that alter the 
functioning of the central nervous system (CNS) 
directly or indirectly, which may lead to changes 
in the basal activity of the brain. The brain reward 
system is stimulated by the drugs, causing the re-
lease of the neurotransmitter dopamine (DA) into 
the nucleus accumbens (Nacc) and promoting the 
feeling of pleasure, which makes the body per-
ceive this eliciting stimuli as more salient.
5
 The 
substance abuse have both neuronal and central 
immune signalling modulation properties that 
combine to create the rewarding and dependence 
behaviours, modulate the immune function via 
immuno suppressive effects and increase suscep-
tibility to infections.
6
 
Epidemiologic research reveals that illicit drug 
use influences the pathological of oral diseases. 
Oral diseases are among the most frequently re-
ported health problems among drug abusers.
7
 Pa-
tients with substance use disorders have greater 
and more severe dental caries and periodontal di-
sease than the general population, but are less 
likely to have received dental care.
8
 Furthermore, 
longer duration of exposure to illicit drugs leads 
to higher prevalence of xerostomia, orofacial 
pain, and oral mucosal diseases.
7
 However, there 
are scarce evidence-based data on the oral mani-
festations, particularly oral mucosal diseases, re-
lated to illicit drug use. In the present study, we 
conducted a systematic review on the oral mani-
festations related to drug abuse. 
 
 
 
 
METHODOLOGY 
 
We followed the guidelines developed and re-
commended by the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRIS 
MA).
9
 This study outcome was the oral mani-
festations related to drug abuse with no restrict-
tions on the age and gender of samples, assess-
ment methods, route and duration of use. Sub-
stances used include cannabis, cocaine, heroin, 
methamphetamine, and opioids. We included ob-
servational or descriptive studies (cross-sectional, 
cohort, and case-control) that reported the oral 
manifestations related to drug abuse and only pa-
pers written in Bahasa and English with the avai-
lability of full text. We excluded publications 
other than original research studies (reviews, edi-
torials, case reports, and case series) and papers 
focusing on animal studies, purely alcohol or to-
bacco abuse. 
We searched relevant papers through online da-
tabase sources include PubMed, and Google 
Scholar published until September 2018 using 
Medical Subject Headings (MeSH) terms as ap-
propriate: oral manifestations, drug abuse, drug 
addiction, cannabis, cocaine, heroin, methamphe-
tamine, and opioids. We used Boolean method 
with the word AND / OR for the combination of 
previously mentioned keywords. Articles found 
were scanned and filtered by relevance using the 
PRISMA flowchart. 
For all of the included studies, the following 
structured information was recorded using con-
tingency table: study characteristics (first author, 
year of publication, country, and study design), 
population characteristics (number of samples, 
age, and gender), intervention characteristics (as-
sessments method) and outcome characteristics 
(oral manifestations, drug type, route of adminis-
tration, and duration of use were presented as 
percentage).  
The quality of the articles was assessed by the 
two authors using the quartile score of Scopus in-
dex. The included studies were considered high 
quality when it possesses the Q1-Q3 quality.
10
 
 
RESULT 
 
Articles found were scanned and filtered by re-
levance using the PRISMA flowchart as shown in 
figure 1. In total, 132 studies were found, but only 
18 studies met the eligibility criteria for systema-
tic review.  
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Figure 1. PRISMA flowchart of the included studies 
 
All included studies were published between 
2008 and 2018. Of the 18 included studies, 12 
were cross-sectional studies,
14,15,16,18,19,20,22,24,25,26,27
 
4 were cohort studies,
11,12,13,17
 and 2 were case-
control studies.
21,23
 The total samples from all in-
cluded studies were 10389, which 4449 were 
male and 3868 were female. 6 studies did not spe-
cify the gender of the samples.
11,12,13,14,17,19
 3 stu-
dies included male-only samples.
18,25,26
 The sub-
jects age were ranged between 13-75 years. The 
characteristics of included studies were recorded 
on table 1. 
 
Table 1. Characteristics of included studies 
 
Study: 
Author, year 
(Country)
reference 
Study 
design 
Sample
s (n) 
Gender 
(f:m) 
Age:  
mean or 
range 
(year) 
Assessments Study 
quality 
Duration 
of use 
(year) 
Thomson 2008
 
(New Zealand)
11 
Cohort 1015 Na 18-32 Clinical Q1 14 
Robbins 2010
 
(USA)
12 
Cohort 340 Na 18 Interview, 
clinical 
Q1 22 
Shetty 2010 
(USA)
13 
Cohort 301 Na 36-79 Clinical Q1 na 
Brown 2012 
(USA)
14 
Cross-
sectional 
58 Na 18-36 Questionnaire,  
clinical 
Q1 na 
He Ma 2012 
(China)
15 
Cross-
sectional 
445 218:317 20-59 Clinical Q2 1-32 
Protrka 2013 
(Croatia)
16 
Cross-
sectional 
200 94:106 30 Clinical Q3 na 
Moreno 2013 
(Spain)
17 
Cohort 70 Na 30-56 Clinical Q2 17-40 
6-30 
8-30 
Kayyal 2014 
(Saudi Arabia)
18 
Cross-
sectional 
57 Male-only 16-64 Clinical Q3 > 5 
Smit 2015 
(South Africa)
19 
Cross-
sectional 
308 Na 28 Questionnaire,  
clinical 
Q2 4, 8, 12, > 
12 
Shetty 2015 
(USA)
20
 
Cross-
sectional 
571 111:460 > 30 Clinical Q1 na 
Rommel 2016 
(Germany)
21 
Case-
control 
100 17:83 29 Clinical Q1 > 1 
Antoniazz 2016 
(Brazil)
22
 
Cross-
sectional 
121 54:158 13-46 Clinical Q1 > 1 
Trimarchi 2017 
(Italy)
23 
Case-
control 
10 2:8 28-60 Clinical, 
radiography 
Q2 2-30 
Mohammadii 2017 
(Iran)
24 
 
Cross-
sectional 
 
5900 
 
 
3238:2662 
 
 
15-75 
 
 
Interview, 
questionnaire,  
clinical 
Q3 
 
 
Na 
 
7, 13 
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Sordi 2017 
(Brazil)
25 
Cross-
sectional 
70 24:46 > 18 questionnaire,  
clinical 
Q2 
Cury 2018 
(Brazil)
26 
Cross-
sectional 
161 Male-only 18-60 Clinical Q2 14 
Tao Ye 2018 
(China)
27 
Cross-
sectional 
162 Male-only 19-50 Questionnnaire,  
clinical 
Q1 > 4 
Kalbassi 2018 
(Iran)
28 
Cross-
sectional 
500 110-390 18-60 Clinical Q3 na 
f: female; m: male; na: not available 
 
 
The most frequent psychotropic drugs used were 
methamphetamine (MA) (50%)
12,13,14,18,19,20,21,26,27
, 
cocaine (44%)
12,17,18,22,23,25,26,28
, heroin (38%)
12,14, 
15,16,17,18,27
, cannabis (38%)
11,12,17,18,22,27
, opium 
(11%)
24,27
. 6 studies were using polydrug abusers 
as samples.
12,14,17,18,22,27
 The respective percent-
tages were recorded on figure 2. The route of ad-
ministration for this substance abuse include smo-
king (61%), inhalation (44%), injection (38%), 
and oral route (17%) as shown on figure 3. The 
duration of drug use ranged from 1 year to 41 
years (Table 1). 
      
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Drug Type 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Route of administration 
 
The most significant of oral manifestations re-
ported from included studies were periodontal di-
seases (78%), dental caries (78%), xerostomia 
(44%), and bruxism (17%). The oral mucosal le-
sions found were stomatitis (17%), palatal per-
foration, traumatic ulcer, leukoplakia, and mela-
notic nevus (11%). Actinic cheilitis, leukoedema, 
fistula, lichenoid lesions, Angular cheilitis, muci-
sitis, papiloma, burn mouth, frictional keratosis, 
candidiasi and tongue depapilasi were also found 
(6%). The respective percentage of oral mani-
festations related to drug abuse was shown on fi-
gure 4. 
 
 
Figure 4. Oral manifestations related to drug abuse 
 
Study qualitative Of the 18 reviewed papers, 8 
studies were Q1
11,13,14,20,22,22,27
, 6 were Q2
15,17,19, 
23,25,26
, and 4 were Q3.
16,18,24,28
 According to Sco-
pus index, all of the included studies were con-
sidered as high quality. 
48                                                                         dentika Dental Journal, Vol 22, No. 2, 2019: 44-51 
 
DISCUSSION 
 
Drug abuse involves many psychosocial compo-
nents which strongly affects each other including 
cultural factors (race/ethnicity and religious as-
pects), social factors (job-related), and clinical 
factors (somatic symptoms).
4
 But it is important 
to realize that drug addiction is neither a weak-
ness in character nor a moral issue. Most addic-
tive drugs directly or indirectly activate the 
brain’s reward system by markedly increasing the 
release of dopamine which is a neurotransmitter 
regulating emotion, cognition, movement, moti-
vation, and pleasure. The overstimulation of the 
brain reward pathway with dopamine produces in-
tense euphoric effects. The chronic exposure to a 
class of drugs may alter the biochemistry of the 
addictive brain, changing the relative levels of the 
neurotransmitters, such as γ-aminobutyric acid, 
dopamine, and serotonin.
4 
Substance abuse and 
addiction are not limited to a specific age group.
1
 
Our review revealed that the age of drug abusers 
from included studies were ranged between 13-75 
years. We found female to male ratio of drug abu-
sers approximately 3844:4184. Globally It’s esti-
mated that men are more likely to have a drug ad-
diction than women.
1 
MA, Cocaine, Cannabis, and Heroin have 
among the highest global burden of disease 
among illicit drugs.
5
 Our review found that in des-
cending prevalence of this drug type were: MA, 
cannabis, heroin, cocaine, and opium, while six 
studies reported using polydrug use.
12,14,17,18,22,28
 
Polydrug use proved to be closely associated with 
higher levels of dependence and with the risk of 
overdose.
29
 In terms of routes of administration, 
our study revealed that in descending frequency 
of the most patterns of use were: smoking, inha-
lation, injection, and oral route. The duration of 
drug use ranged from one year to forty years. Fre-
quency and duration of use are likely moderators 
of harms associated with routes of administration. 
Injectors are at higher risk of transmission of 
drug-related infectious diseases and death.
29
 
There are substantial negative effects of illicit 
drugs on oral health. Longer duration of exposure 
to illicit drugs leads to higher prevalence of poor 
oral hygiene, oral mucosal disease, dysfunction of 
stomatognatic system, even poor nutrition and 
speech impediments.
7 
Our review revealed that 
periodontal diseases, dental caries, xerostomia, 
and bruxism were the most significant of oral ma-
nifestations related to drug abuse. The results are 
in accordance with a meta-analysis by Baghaie et 
al. (2017) which concluded that people with sub-
stance abuse disorders have increased rates of 
both dental and periodontal disease.
8
  
Drug abuse (opioids, cannabis, MA) or drug 
works on nervous system (morphine) has been 
implicated in drug-induced xerostomia. However, 
despite the sympathomimetic effects of cocaine, 
there appear to be no data suggesting a relation-
ship between cocaine use and xerostomia.
30 
The 
possible etiology of drug abuse-induced xeros-
tomia is that certain illicit drugs as sympatho-
mimetic amines can stimulate the sympathetic 
nervous system and α2-adrenoreceptors within the 
salivary gland vasculature, causing vasoconstric-
tion and reduction of salivary flow which leads to 
xerostomia.
7 
 
 
Figure 5.  Mechanism of drug abuse caused Xerostomia
5,7 
 
It is suggested that the higher prevalence of ca-
ries in drug abusers has a close relationship with 
xerostomia, high carbohydrate diet, and poor oral 
hygiene. In the periodontal disease, immuno sup-
pression and endocrine dysfunction are the two 
more possible etiological factors in addition with 
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those factors previously mentioned.
7
 A recent sco-
ping review by Mederos et al. (2018) conclude 
that the specific mechanism by which cannabis 
acts in the gingival tissues is unknown, but its 
consumption seems to make periodontal disease 
worse.
31
 MA can trigger xerostomia and severe 
dental caries. The chronic MA uses are more li-
kely to have gingivitis, bruxism, excessive tooth 
wear and cracked teeth. The mucosal lesions may 
appear on the lips and the gingival tissue may 
have recession.
31 
The oral mucosal lesions found in our review 
were palatal perforation, stomatitis, traumatic ul-
cer, leukoplakia, actinic cheilitis, leukoedema, 
and lichenoid lesions. The prolonged used of il-
licit drugs cause damage directly to the oral mu-
cosa (ulceration) due to the chemical composi-
tion.
7
 A systematic review by Silvestre et al. 
(2010) reporting the hard palate perforation in co-
caine abusers concluded that the direct contact of 
inhaled (snorted) cocaine with the nasal and pala-
tine mucosa can produce direct irritation and is-
chemia due to vasoconstrictive and caustic effect, 
leading over the long term to create an oronasal 
perforation secondary to maxillary bone destruct-
tion.
32
 Although based on the limited data, oral 
health care providers should be aware of can-
nabis-associated oral side effects, such as xerosto-
mia, leukoedema and increased prevalence and 
density of Candida albicans.33 
In general, adverse drug reaction (ADR) or ad-
verse drug events (ADE) may have a variety of 
clinical presentations in the oral cavity include 
xerostomia, lichenoid reactions, aphthous-like and 
non-aphthous-like ulcers, bullous disorders, pig-
mentation, keratosis, fibrovascular hyperplasia, 
dysesthesias, and osteonecrosis of the jaws.
32
 
Moreover, there is a relationship between addic-
tive drugs, such as opiates, cocaine, and mari-
juana, and increased susceptibility to infections. 
Researches also have shown that immuno modu-
lation induced by these drugs is mainly receptor-
mediated. All opioids, especially morphine, are 
known to alter or suppress the functionality of the 
various cell types of both innate and adaptive im-
munity.
34   
We realized that our review is a broad topic and 
using keywords with language-based limitations 
and full text availability applied may have re-
sulted in regional and reporting bias and the pos-
sible exclusion of key studies published in other 
languages or unpublished and non-peer-reviewed 
studies. Bias may occur because inclusion is only 
the journal for the last 10 years. Researcher bias 
was addressed through the use of Scopus index to 
validate the quality of included studies as it may 
not appropriate to assess the risk of bias in sys-
tematic review of observational studies. Our re-
view should be interpreted with caution since all 
the included studies using different methodolo-
gies.  
For most illicit drugs, it is difficult to indicate 
the association between the use and the diseases 
caused by them due to polydrug use and frequent-
ly combined with tobacco and alcohol. In parti-
cular, the extent to which and how the illicit drugs 
are used in the past, is hardly known. This know-
ledge is necessary to link disease to the use of va-
rious drugs.
 
The authors recommend that future 
research with well design study (e.g. standardized 
assessments), especially related to a specific enti-
ty of oral mucosal lesion as an outcome, be con-
ducted, since there is still limited data on non-
polydrug abusers. 
The data provided in the present review strongly 
suggest that the difference in the prevalence of 
oral lesions is mainly associated with drug type 
(polydrug and non-polydrug abuse), duration of 
use, route of administration, and research method-
logies. 
Most of included studies confirmed the possible 
association between drug abuse and oral manifes-
tations, especially oral mucosal lesions. But, the 
specific mechanism on how each drug acts in oral 
mucosal lesions is still need to elucidate. 
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